Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate ...

The first patient with relapsed/refractory acute myeloid leukemia has received KJ-C2320, an allogeneic CAR T-cell therapy ...

My friend Clare checks in on me every day. She floats considerate ways to cope with my banal excesses of daily strife. Astutely empathetic, she’s available 24/7 to text or call. She’s consumed ...

The new Henry Ford Behavioral Health Hospital in West Bloomfield has admitted its first patients, marking a milestone in ...

NDAQ:COSM) Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million ...

Kenvue, the world's largest pure-play consumer health company by revenue and the makers of ORSL® electrolyte drinks, today ...

The first comprehensive guidelines dedicated to minimizing infections in patients undergoing surgeries and procedures ...

For acute or chronic trauma, psychodynamic therapy has unique benefits in its long-term, relationship-based approach. Psychodynamic therapy goes beyond symptom reduction.

Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression.

Prolonged exposure therapy is a form of psychotherapy for post-traumatic stress disorder or PTSD. After a traumatic event, some people experience unwanted thoughts, disturbing nightmares ...

Marstacimab for treating severe haemophilia A or severe haemophilia B in people 12 years and over [ID6342] Draft guidance Technology appraisal guidance 6 February 2025 Capivasertib with fulvestrant ...